Royalty Pharma RPRX
NASDAQ RPRX
$68.82 +0.05 (+0.07%)
As of: Nov 10, 2026 · 1:46 PM EST

Royalty Pharma (RPRX) Acquisitions (2025)

Updated

Royalty Pharma's Acquisitions came in at $74.42 million for FY2025.

Analysis

Royalty Pharma (RPRX) Acquisitions (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Rocket Companies 40.96 Bn 29.78 Bn - -
2 Orix 36.82 Bn 3.63 Bn - -
3 Royalty Pharma 30.51 Bn 27.88 Bn - -
4 Federal National Mortgage Association Fannie Mae 26.64 Bn 26.64 Bn - -
5 Royal Gold 23.60 Bn 22.77 Bn 390.45 Mn -
6 Synchrony Financial 23.18 Bn -44.45 Bn - -
7 Affirm Holdings 23.17 Bn 16.22 Bn - -
8 Annaly Capital Management 14.38 Bn 5.33 Bn - -
9 Ares Capital 13.91 Bn 11.66 Bn - -
10 Federal Home Loan Mortgage 12.97 Bn -5.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 226,000.00
API Access

Royalty Pharma Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=RPRX&period=max&api_key=YOUR_API_KEY